Today, we are joined by Dr. Bin Cao, the vice director of the National Clinal Research Center for Respiratory Diseases in the Peoples Republic of China. In this episode, we discuss Dr. Cao's paper published in The New England Journal of Medicine titled, "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19".

Thanks for joining us for this wonderful opportunity to learn from one of the leading researchers on the COVID pandemic. Enjoy!

Talking Points:

• About this podcast and our mission (0:00)
• Dr. Cao's describes his journey treating COVID-19 (1:10)
• Who discovered COVID-19? (1:35)
• The first month in Wuhan (2:12)
• Past experiences in clinical research (3:20)
• The three independent risk factors of COVID (5:28)
• Treatment for SARS and the relationship to COVID-19 (7:17)
• Advice for healthcare workers (8:40)
• Issues with vaccine development and next steps (11:00)
• Antibody-dependent enhancement (11:53)
• Final thoughts (13:00)

Today, we speak with Dr. Kostas Danis, a physician/epidemiologist with the department of infectious diseases in the French National Public Health Agency. In this episode, we discuss his paper published in Journal: Clinical Infectious Diseases, titled, "Cluster of Coronavirus Disease 2019 (Covid-19) in the French Alps."

Thanks for joining us for this wonderful opportunity to learn from one of the leading researchers on the COVID pandemic. Enjoy!

Talking Points:

• About this podcast and our mission (0:00)
• Dr. Danis role in the fight against COVID-19 (1:06)
• Mortality in nursing homes in the COVID era (2:02)
• The trajectory of response to COVID-19 in France (2:35)
• A look into the beginning of COVID-19 in France (3:41)
• Dr. Danis shares more findings in his paper (5:44)
• Insight into the transmission of COVID-19 in children (6:34) 
• The need for testing (8:32)
• Questions that need answers surrounding this pandemic (9:26)
• Dr. Danis shares his current work in nursing homes in France (10:03)
• Final thoughts (11:11)

Today, we interview Dr. Annelies Wilder-Smith, a renowned expert on public health and professor of infectious disease research at the Lee Kong Chian School of Medicine in Singapore. In this episode, we discuss Dr. Wilder-Smith's paper published in Lancet Infectious Diseases titled, "Can We Contain the COVID-19 Outbreak With the Same Measures as for SARS?".

Thanks for joining us for this wonderful opportunity to learn from one of the leading researchers on the COVID pandemic. Enjoy!

Talking Points:

• About this podcast and our mission (0:00)
• Experiences with SARS in Singapore (1:15)
• China's methods of controlling SARS (3:12)
• COVID and SARS characteristics (3:40)
• Differences between the response in Western and Asian countries. (5:00)
• The importance of testing (5:52)
• Pandemic response in megacities (6:29)
• Adapting community-based quarantine (7:43)
• Precision quarantine (9:15)
• Final thoughts (9:45)